INMODE LTD (INMD)
IL0011595993 - Common Stock
INMD Crosses Above Key Moving Average Level
InMode to Present at Upcoming Investor Conferences
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following...
InMode (INMD) Q3 2024 Earnings Call Transcript
INMD earnings call for the period ending September 30, 2024.
InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial...
InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has been granted a preliminary injunction by the U.S....
Notable Tuesday Option Activity: DASH, HOUS, INMD
InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies today announced the departure of Shakil Lakhani,...
Notable Tuesday Option Activity: AMBC, THO, INMD
InMode to Present at 2024 Baird Global Healthcare Conference
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial...
InMode to Present at Upcoming Investor Conferences
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following...
InMode (INMD) Q2 2024 Earnings Call Transcript
INMD earnings call for the period ending June 30, 2024.
Notable Thursday Option Activity: ALNY, PRIM, INMD
InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is pleased to announce the introduction of IgniteRF,...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer
/PRNewswire/ -- DOMA Perpetual Capital Management LLC today sent a letter to the Board of Directors of InMode (NYSE: INMD) urging the Board to execute a 40%...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
/PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, is pleased to announce an additional FDA 510(k)...
Notable Thursday Option Activity: ACI, INMD, OXY
3 MedTech Stocks to Buy for Healthy Gains
With innovations in healthcare moving at a rapid clip, investors should consider these enticing MedTech stocks to buy.
Noteworthy Friday Option Activity: CBL, DLTR, INMD
InMode to Present at Jefferies Healthcare Conference
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial...
InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is the first aesthetic company to officially partner...
InMode (INMD) Q1 2024 Earnings Call Transcript
INMD earnings call for the period ending March 31, 2024.
INMD Stock Earnings: InMode Misses EPS, Misses Revenue for Q1 2024
INMD stock results show that InMode missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M;
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial...
Commit To Purchase InMode At $10, Earn 11% Using Options
INMD DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages InMode Ltd. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action - INMD
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of InMode Ltd. (NASDAQ: INMD) between June 4, 2021...
INMD DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages InMode Ltd. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action - INMD
WHY: NEW YORK, NY - (NewMediaWire) - April 15, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of InMode Ltd. (NASDAQ: INMD) between June 4, 2021 and October 12, 2023, both dates inclusive (the “Class Period”), of the important April 15, 2024 lead plaintiff deadline.
INMD DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages InMode Ltd. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action - INMD
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, responded to the recent petition to the U.S. Patent &...
Shareholders of InMode Ltd. Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights - INMD
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in InMode Ltd. ("InMode" or the "Company") (NASDAQ: INMD) of a class action securities lawsuit. CLASS...
INMD FINAL DEADLINE: ROSEN, A LEADING AND RANKED FIRM, Encourages InMode Ltd. Investors with Losses in Excess of $100k to Secure Counsel Before Important April 15 Deadline in Securities Class Action - INMD
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
INMD FINAL DEADLINE: ROSEN, A LEADING AND RANKED FIRM, Encourages InMode Ltd. Investors with Losses in Excess of $100k to Secure Counsel Before Important April 15 Deadline in Securities Class Action - INMD
WHY: NEW YORK, NY - (NewMediaWire) - April 14, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of InMode Ltd. (NASDAQ: INMD) between June 4, 2021 and October 12, 2023, both dates inclusive (the “Class Period”), of the important April 15, 2024 lead plaintiff deadline.
INMD DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages InMode Ltd. Investors with Losses in Excess of $100k to Secure Counsel Before Important April 15 Deadline in Securities Class Action - INMD
WHY: NEW YORK, NY - (NewMediaWire) - April 13, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of InMode Ltd. (NASDAQ: INMD) between June 4, 2021 and October 12, 2023, both dates inclusive (the “Class Period”), of the important April 15, 2024 lead plaintiff deadline.
INMD DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages InMode Ltd. Investors with Losses in Excess of $100k to Secure Counsel Before Important April 15 Deadline in Securities Class Action - INMD
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InMode
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against InMode Ltd. ("InMode" or the "Company")...
INMD DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages InMode Ltd. Investors with Losses in Excess of $100k to Secure Counsel Before Important April 15 Deadline in Securities Class Action - INMD
WHY: NEW YORK, NY - (NewMediaWire) - April 12, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of InMode Ltd. (NASDAQ: INMD) between June 4, 2021 and October 12, 2023, both dates inclusive (the “Class Period”), of the important April 15, 2024 lead plaintiff deadline.
INMD DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages InMode Ltd. Investors with Losses in Excess of $100k to Secure Counsel Before Important April 15 Deadline in Securities Class Action - INMD
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.